The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali

SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011 Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 PART-A Name of the Target Company (TC) Asston Pharmaceuticals Limited Name(s) of the acquirer and Persons Acting in Prakruti R Pali Concert (PAC)with the acquirer Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock Exchange(s) where the Bombay Stock Exchange SME Platform shares of TC are listed Details of the acquisition/disposal as follows Number % w.r.t.total % w.r.t. total share/voting diluted capital share/voting wherever capital of the applicable(*) TC (**) Before the acquisition under consideration, holding of: Shares carrying voting rights 6,18,000 7.26 % 7.26 % Shares in the nature of encumbrance (pledge/ 0 0 0 lien/ non-disposal undertaking/ others) Voting rights (VR) otherwise than by shares 0 0 0 Warrants/convertible securities/any other 0 0 0 instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) Total 6,18,000 7.26% 7.26 % Details of acquisition/sale: Shares carrying voting rights acquired/sold 1,51,000 1.77 % 1.77 % VRs acquired /sold otherwise than by shares 0 0 0 Warrants/convertible securities/any other 0 0 0 instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold Shares encumbered / invoked/released by the 0 0 0 acquirer Total 1,51,000 1.77 % 1.77 % After the acquisition/sale, holding of: Shares carrying voting rights 7,69,000 9.03 % 9.03 % Shares encumbered with the acquirer 0 0 0 VRs otherwise than by shares 0 0 0 Warrants/convertible securities/any other 0 0 0 instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition Total 7,69,000 9.03% 9.03 % Mode of acquisition / sale (e.g. open market / off- Open Market market / public issue / rights issue / preferential allotment / inter-se transfer etc). Salient features of the securities acquired Fully paid up equity share acquired including time till redemption, ratio at which it can be converted into equity shares etc. Date of acquisition/sale of shares / VR or date 01st September, 2026 of receipt of intimation of allotment of shares, whichever is applicable Equity share capital / total voting capital of the 6,18,000 Equity Shares TC before the said acquisition/sale Equity share capital/ total voting capital of the 7,69,000 Equity Shares TC after the said acquisition/sale 7,69,000 Equity Shares Total diluted share/voting capital of the TC after the said acquisition Signature of the acquirer/Authorized Signatory Date: 03/09/2026 Place: Mumbai PART-B Name of the target company Asston Pharmaceuticals Limited Name(s) of the acquirer and Whether the acquirer PAN of the acquirer and/or Persons Acting in Concert belongs to PACs (PAC)with the acquirer Promoter/Promoter group Prakruti R Pali No ALWPP6255B Signature of the acquirer/Authorized Signatory Date: 03/09/2026 Place: Mumbai (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the Listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. (***) Part-B shall be disclosed to the Stock Exchange but shall not be disseminated.